{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:26:09Z","timestamp":1772151969384,"version":"3.50.1"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2011,4,8]],"date-time":"2011-04-08T00:00:00Z","timestamp":1302220800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0018578","type":"journal-article","created":{"date-parts":[[2011,4,9]],"date-time":"2011-04-09T00:10:57Z","timestamp":1302307857000},"page":"e18578","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Development and Validation of Decision Rules to Guide Frequency of Monitoring CD4 Cell Count in HIV-1 Infection before Starting Antiretroviral Therapy"],"prefix":"10.1371","volume":"6","author":[{"given":"Thierry","family":"Buclin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalio","family":"Telenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Perera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Csajka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hansjakob","family":"Furrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey K.","family":"Aronson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul P.","family":"Glasziou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,4,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.2010.1004","article-title":"Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA Panel.","volume":"304","author":"MA Thompson","year":"2010","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1056\/NEJMcp051203","article-title":"Management of newly diagnosed HIV infection.","volume":"353","author":"SM Hammer","year":"2005","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/bmj.39064.406389.94","article-title":"When should antiretroviral therapy for HIV be started?","volume":"334","author":"AN Phillips","year":"2007","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7326\/0003-4819-148-3-200802050-00004","article-title":"Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model.","volume":"148","author":"RS Braithwaite","year":"2008","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMoa0807252","article-title":"Effect of early versus deferred antiretroviral therapy for HIV on survival.","volume":"360","author":"MM Kitahata","year":"2009","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(09)60612-7","article-title":"Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.","volume":"373","author":"JA Sterne","year":"2009","journal-title":"Lancet"},{"key":"ref7","article-title":"WHO HIV\/AIDS Programme: Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach.","year":"2006"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJMoa0910370","article-title":"Early versus standard antiretroviral therapy for HIVinfected adults in Haiti.","volume":"363","author":"P Severe","year":"2010","journal-title":"N Engl J Med"},{"issue":"S1","key":"ref9","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1086\/375368","article-title":"Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda.","volume":"37","author":"DM Kent","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2471\/BLT.05.021865","article-title":"Diagnostic tests in HIV management: a review of clinical and laboratory strategies to monitor HIV-infected individuals in developing countries.","volume":"84","author":"AD Kimmel","year":"2006","journal-title":"Bull World Health Organ"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1371\/journal.pmed.0050053","article-title":"The impact of monitoring HIV patients prior to treatment in resource-poor settings: insights from mathematical modelling.","volume":"5","author":"TB Hallett","year":"2008","journal-title":"PLoS Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1001\/archinternmed.2008.1","article-title":"Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a Southern African analysis.","volume":"168","author":"E Bendavid","year":"2008","journal-title":"Arch Intern Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1365-3156.2008.02078.x","article-title":"Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America.","volume":"13","author":"M Egger","year":"2008","journal-title":"Trop Med Int Health"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e1949","DOI":"10.1371\/journal.pone.0001949","article-title":"Late entry to HIV care limits the impact of anti-retroviral therapy in The Netherlands.","volume":"3","author":"C Smit","year":"2008","journal-title":"PLoS ONE"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1002\/9780470696323","article-title":"Evidence-based Medical Monitoring: From Principles to Practice","author":"PP Glasziou","year":"2008"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","article-title":"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.","volume":"360","author":"M Egger","year":"2002","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/0962280209359886","article-title":"Statistical models for the control phase of clinical monitoring.","volume":"19","author":"RJ Stevens","year":"2010","journal-title":"Stat Methods Med Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cpt1979263294","article-title":"Forecasting individual pharmacokinetics.","volume":"26","author":"LB Sheiner","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1097\/00002030-199813000-00018","article-title":"Effects of age at seroconversion and baseline HIV RNA level on the loss of CD4+ cells among persons with hemophilia. Multicenter Hemophilia Cohort Study.","volume":"12","author":"G Touloumi","year":"1998","journal-title":"AIDS"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/01621459.1991.10475081","article-title":"Modeling the progression of HIV infection.","volume":"86","author":"V DeGruttola","year":"1991","journal-title":"J Amer Stat Assoc"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/(SICI)1097-0258(19960815)15:15<1663::AID-SIM294>3.0.CO;2-1","article-title":"Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach.","volume":"15","author":"CL Faucett","year":"1996","journal-title":"Stat Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1086\/513970","article-title":"Is there a general tendency for CD4 lymphocyte decline to speed up during human immunodeficiency virus infection? Evidence from the Italian Seroconversion Study.","volume":"175","author":"AC Lepri","year":"1997","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/01621459.1992.10475258","article-title":"Hierarchical Bayes models for the progression of HIV infection using longitudinal CD4 T-cell numbers.","volume":"87","author":"N Lange","year":"1992","journal-title":"J Amer Stat Assoc"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1086\/341833","article-title":"No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study.","volume":"186","author":"C Laurent","year":"2002","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00126334-200309010-00012","article-title":"Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.","volume":"34","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1002\/sim.3294","article-title":"A joint back calculation model for the imputation of the date of HIV infection in a prevalent cohort.","volume":"27","author":"P Taff\u00e9","year":"2008","journal-title":"Stat Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1468-1293.2007.00507.x","article-title":"HIV in the UK 1980\u20132006: reconstruction using a model of HIV infection and the effect of antiretroviral therapy.","volume":"8","author":"AN Phillips","year":"2007","journal-title":"HIV Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00126334-199208000-00005","article-title":"Effect of CD4+ cell count measurement variability on staging HIV-1 infection.","volume":"5","author":"DR Hoover","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/infdis\/174.1.191","article-title":"Variation in plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infection.","volume":"174","author":"JM Raboud","year":"1996","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1002\/(SICI)1097-0258(19971130)16:22<2555::AID-SIM690>3.0.CO;2-Y","article-title":"Bayes estimates for immunological progression rates in HIV disease.","volume":"16","author":"AJ McNeil","year":"1997","journal-title":"Stat Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1097\/01.aids.0000194134.28135.cd","article-title":"Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters.","volume":"19","author":"Y Madec","year":"2005","journal-title":"AIDS"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.","volume":"126","author":"JW Mellors","year":"1997","journal-title":"Ann Intern Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1097\/00002030-200212060-00011","article-title":"Virologic and immunologic values allowing safe deferral of antiretroviral therapy.","volume":"16","author":"JP Phair","year":"2002","journal-title":"AIDS"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jama.296.12.1498","article-title":"Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.","volume":"296","author":"B Rodr\u00edguez","year":"2006","journal-title":"JAMA"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00126334-200007010-00004","article-title":"Association of race and gender with HIV-1 RNA levels and immunologic progression.","volume":"24","author":"K Anastos","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(00)02061-4","article-title":"Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis.","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.aids.0000171400.15619.e1","article-title":"HIV-1 pol replication capacity predicts disease progression.","volume":"19","author":"ES Daar","year":"2005","journal-title":"AIDS"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1023\/B:EJEP.0000032378.98991.59","article-title":"Clinical, immunological and virological evolution in patients with CD4 T-cell count above 500\/mm3: is there a benefit to treat with highly active antiretroviral therapy (HAART)?","volume":"19","author":"L Piroth","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1365-3156.2007.001873.x","article-title":"Effect of pregnancy on HIV disease progression and survival among women in rural Uganda.","volume":"12","author":"L Van der Paal","year":"2007","journal-title":"Trop Med Int Health"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrmicro1532","article-title":"Genomics meets HIV-1.","volume":"4","author":"A Telenti","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1182\/blood-2003-09-3333","article-title":"Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.","volume":"104","author":"SG Deeks","year":"2004","journal-title":"Blood"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/jama.297.21.2349","article-title":"Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection.","volume":"297","author":"JW Mellors","year":"2007","journal-title":"JAMA"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/00365540701708285","article-title":"Slow progression of HIV-1 infection in a cohort of antiretroviral na\u00efve hotel workers in Dar es Salaam, Tanzania as defined by their CD4 cell slopes.","volume":"40","author":"M Bakari","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1086\/648096","article-title":"CD4(+) T cell count decreases by ethnicity among untreated patients with HIV infection in South Africa and Switzerland.","volume":"200","author":"M May","year":"2009","journal-title":"J Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-148-9-200805060-00005","article-title":"Monitoring cholesterol levels: measurement error or true change?","volume":"148","author":"PP Glasziou","year":"2008","journal-title":"Ann Intern Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1468-1293.2008.00642.x","article-title":"A national review of assessment and monitoring of HIV-infected patients.","volume":"10","author":"N Lomax","year":"2009","journal-title":"HIV Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0140-6736(08)60624-8","article-title":"Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model.","volume":"371","author":"AN Phillips","year":"2008","journal-title":"Lancet"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1191\/096228098674392113","article-title":"Longitudinal models for AIDS marker data.","volume":"7","author":"WJ Boscardin","year":"1998","journal-title":"Stat Met Med Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0018578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T14:26:16Z","timestamp":1540218376000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0018578"}},"subtitle":[],"editor":[{"given":"Landon","family":"Myer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,4,8]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,4,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0018578","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,8]]}}}